Bentham Science Logo

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 19, 8 Issues, 2019
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 15 - Number 3



One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?

, 15(3): 171 - 185

Matteo A. Russo, Luigi Sansone, Ilaria Carnevale, Federica Limana, Alessandra Runci, Lucia Polletta, Giulietta A. Perrone, Elena De Santis and Marco Tafani


DOI: 10.2174/1871530315666150316120112




IL-1 as a target in inflammation

, 15(3): 206 - 211

Yuki Ito, Naoe Kaneko, Tomoyuki Iwasaki, Shinnosuke Morikawa, Kentaro Kaneko and Junya Masumoto


DOI: 10.2174/1871530315666150316123657





Objective Assessment of the Rheological Muscle Property in the Treatment of Fibromyalgia

, 15(3): 229 - 233

Riccardo Marvulli, Giancarlo Ianieri, Lucia Mastromauro, Ersilia Romanelli, Laura Barulli, Pierpaolo Chiumarulo, Gianfranco Megna and Marisa Megna


DOI: 10.2174/1871530315666150324112722






Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.93



Related Journals

Related eBooks

eBooks Catalog